ClinicalTrials.gg
RecruitingNCT07665944SPIN-BP-NOUpdated Jun 24, 2026

Hydroponic vs Conventional Spinach Smoothies: Effects on Salivary Nitrate Bioavailability and Blood Pressure

An interventional study of Hydroponic spinach smoothie and Conventional spinach smoothie in Adult, sponsored by University of Plymouth. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by University of Plymouth · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The goal of this clinical trial is to determine whether hydroponic spinach (HS) versus conventional spinach (CS) smoothies produce differential post-consumption effects on salivary nitrate availability and blood pressure in adults.

The main questions it aims to answer are:

Do hydroponic spinach (HS) and conventional spinach (CS) smoothies produce differential post-consumption salivary nitrate availability responses in adults when consumed in equal volumes? Do hydroponic spinach (HS) and conventional spinach (CS) smoothies produce differential post-consumption blood pressure responses in adults when consumed in equal volumes?

Participants will:

Consume hydroponic spinach (HS) and conventional spinach (CS) smoothies on two separate study days.

Attend two laboratory visits at the university, scheduled within a 1-2 week period.

Undergo check-ups and study measurements during each visit (e.g., blood pressure and saliva sampling).

Read the detailed description

This randomized, double-blind, crossover study will investigate the acute effects of hydroponic spinach (HS) compared with conventional spinach (CS) smoothies on vascular responses in adults. The study aims to determine whether HS and CS smoothies elicit differential effects on nitrate bioavailability and blood pressure.

Spinach is a rich source of dietary nitrate, which can be converted via the enterosalivary pathway to nitrite and subsequently to nitric oxide, a key regulator of vascular function and blood pressure. The nitrate content of spinach varies according to cultivation methods, with hydroponically grown spinach often reported to have higher nitrate concentrations than conventionally grown spinach. However, it remains unclear whether these compositional differences translate into meaningful physiological effects following consumption.

Participants will attend two laboratory visits separated by a washout period of approximately 7-14 days. In this randomized crossover design, each participant will receive both interventions in a randomized order, enabling within-subject comparisons. At each visit, participants will consume a standardized smoothie containing either hydroponic or conventional spinach. The smoothies will be matched for volume and appearance to maintain blinding of both participants and investigators.

Baseline measurements will be obtained prior to smoothie consumption. Following intake, measurements will be repeated over the acute postprandial period, including at 2 hours post-consumption, to assess physiological responses. These assessments will include saliva samples to evaluate nitrate bioavailability (salivary nitrate) and cardiovascular measures-systolic blood pressure, diastolic blood pressure, mean arterial pressure (MAP), and heart rate (HR).

The crossover design allows each participant to act as their own control, thereby reducing inter-individual variability and improving statistical power in this pilot investigation.

02

Conditions studied

  • Adult

Keywords

  • spinach
  • Hydroponic agriculture
  • Conventional agriculture
  • Dietary nitrate
  • Nitrite
  • Nitric oxide
  • Blood pressure
  • Crossover study
  • Randomized controlled trial
  • Smoothie intervention
  • Postprandial response
  • Saliva biomarkers
  • Nitrate bioavailability
03

In context

Lead sponsor

University of Plymouth is the lead sponsor of 49 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-60 years
  • Generally healthy individuals (no diagnosed chronic disease)
  • Non-smokers and non-vapers
  • Not currently taking medications known to affect cardiovascular function or nitrate metabolism
  • Able and willing to provide
  • Willing to comply with study procedures and attend both study visits

Exclusion criteria

Exclusion Criteria:

  • Presence of chronic disease (e.g., cardiovascular, metabolic, renal, or respiratory conditions)
  • Use of pacemakers or implanted medical devices
  • Pregnant or lactating individuals
  • Known allergy or intolerance to spinach
  • History of gastrointestinal disorders or pathology affecting digestion or absorption
  • Use of nitrate or nitrite supplements
  • Use of antibiotics within the past 3 weeks
  • Use of antibacterial mouthwash or oral products within the past 2 weeks
  • Current participation in another clinical trial or recent participation that may interfere with outcomes
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Hydroponic then Conventional Spinach

    Participants consume a hydroponic spinach smoothie at the first visit followed by a conventional spinach smoothie at the second visit, separated by a washout period.

    Other: Hydroponic spinach smoothie · Other: Conventional spinach smoothie

  • Experimental
    Conventional then Hydroponic Spinach

    Participants consume a conventional spinach smoothie at the first visit followed by a hydroponic spinach smoothie at the second visit, separated by a washout period.

    Other: Hydroponic spinach smoothie · Other: Conventional spinach smoothie

Interventions

  • OtherHydroponic spinach smoothie

    Standardized smoothie prepared with hydroponically grown spinach, matched for volume and appearance.

  • OtherConventional spinach smoothie

    Standardized smoothie prepared with conventionally grown spinach, matched for volume and appearance.

06

What researchers measure

Primary outcomes

  1. Salivary nitrate concentration

    Salivary nitrate levels assessed at baseline and 2 hours post-consumption as a marker of nitrate bioavailability.

    Time frame: Baseline and 2 hours post-consumption

Secondary outcomes

  1. Systolic blood pressure

    Systolic blood pressure measured at baseline and 2 hours after consumption of hydroponic and conventional spinach smoothies.

    Time frame: Baseline and 2 hours post-consumption

  2. Diastolic blood pressure

    Diastolic blood pressure measured at baseline and 2 hours after consumption of hydroponic and conventional spinach smoothies.

    Time frame: Baseline and 2 hours post-consumption

  3. Mean arterial pressure

    Mean arterial pressure measured at baseline and 2 hours post-consumption.

    Time frame: Baseline and 2 hours post-consumption

  4. Heart rate

    Heart rate measured at baseline and 2 hours post-consumption.

    Time frame: Baseline and 2 hours post-consumption

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Qadir OK, Seal CJ, Ashor AW, Tassotti M, Mena P, Del Rio D, Siervo M, Brandt K. Double-blind controlled dietary cross-over intervention with differentially fertilised intact lettuce leaves shows acute reduction in blood pressure in young adults, associated with faster uptake of nitrate than of phenolics. Eur J Nutr. 2022 Dec;61(8):4191-4203. doi: 10.1007/s00394-022-02961-5. Epub 2022 Jul 23. PubMed 35871120 ↗
  • Jackson JK, Patterson AJ, MacDonald-Wicks LK, Oldmeadow C, McEvoy MA. The role of inorganic nitrate and nitrite in cardiovascular disease risk factors: a systematic review and meta-analysis of human evidence. Nutr Rev. 2018 May 1;76(5):348-371. doi: 10.1093/nutrit/nuy005. PubMed 29506204 ↗
  • Hosseini MJ, Dezhangah S, Esmi F, S Gharavi-Nakhjavani M, Hashempour-Baltork F, Mirza Alizadeh A. A worldwide systematic review, meta-analysis and meta-regression of nitrate and nitrite in vegetables and fruits. Ecotoxicol Environ Saf. 2023 Jun 1;257:114934. doi: 10.1016/j.ecoenv.2023.114934. Epub 2023 Apr 19. PubMed 37084661 ↗
  • Bryan NS, Ahmed S, Lefer DJ, Hord N, von Schwarz ER. Dietary nitrate biochemistry and physiology. An update on clinical benefits and mechanisms of action. Nitric Oxide. 2023 Mar 1;132:1-7. doi: 10.1016/j.niox.2023.01.003. Epub 2023 Jan 20. PubMed 36690137 ↗
  • Blekkenhorst LC, Bondonno NP, Liu AH, Ward NC, Prince RL, Lewis JR, Devine A, Croft KD, Hodgson JM, Bondonno CP. Nitrate, the oral microbiome, and cardiovascular health: a systematic literature review of human and animal studies. Am J Clin Nutr. 2018 Apr 1;107(4):504-522. doi: 10.1093/ajcn/nqx046. PubMed 29635489 ↗
  • Bian Z, Wang Y, Zhang X, Li T, Grundy S, Yang Q, Cheng R. A Review of Environment Effects on Nitrate Accumulation in Leafy Vegetables Grown in Controlled Environments. Foods. 2020 Jun 3;9(6):732. doi: 10.3390/foods9060732. PubMed 32503134 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2026 (actual). Primary completion is estimated for Jun 2026, 0 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2026
First posted
Jun 24, 2026
StartActual
May 22, 2026
Primary completionEst.
Jun 19, 2026
CompletionEst.
Jul 31, 2026
Last update
Jun 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07665944
Lead sponsor
University of Plymouth
Responsible party
Raul Bescos (Associate Professor of Human Nutrition and Physiology, University of Plymouth) — Principal investigator
First posted
Jun 24, 2026
Start date
May 22, 2026
Primary completion
Jun 19, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
Jun 24, 2026

Study contacts

Raul Bescos, PhD
Contact
raul.bescos@plymouth.ac.uk
+44 1752 587585
Patricia Casas Agustench, PhD
Contact
patricia.casas@plymouth.ac.uk
+44 1752 588892

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion